Published in J Neurosci on May 15, 2001
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Donald Munro Lecture. Spinal cord injury--past, present, and future. J Spinal Cord Med (2007) 2.32
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci (2006) 1.48
Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ (2009) 1.37
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience (2008) 1.30
The ladder rung walking task: a scoring system and its practical application. J Vis Exp (2009) 1.22
Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush. J Neurosci (2009) 1.20
A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma (2010) 1.10
White matter inhibitors in CNS axon regeneration failure. Exp Neurol (2007) 1.10
Plasticity of connections underlying locomotor recovery after central and/or peripheral lesions in the adult mammals. Philos Trans R Soc Lond B Biol Sci (2006) 1.08
Neurobiology of rehabilitation. Ann N Y Acad Sci (2004) 1.06
Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab (2010) 1.06
Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res (2007) 1.05
A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci Res (2010) 1.04
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther Clin Risk Manag (2008) 1.04
Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration. J Biol Chem (2009) 1.00
Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem Res (2007) 0.99
Axon growth inhibition by RhoA/ROCK in the central nervous system. Front Neurosci (2014) 0.97
Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth. Glia (2007) 0.97
Epigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward. Neurotherapeutics (2013) 0.94
Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. J Mol Cell Cardiol (2011) 0.93
Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res (2012) 0.93
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc Natl Acad Sci U S A (2001) 0.91
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol (2002) 0.89
Functional delay of myelination of auditory delay lines in the nucleus laminaris of the barn owl. Dev Neurobiol (2007) 0.86
Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury. J Neurotrauma (2009) 0.86
Mesenchymal stem cells as an alternative for Schwann cells in rat spinal cord injury. Iran Biomed J (2013) 0.82
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury. J Control Release (2015) 0.81
RA-RAR-β counteracts myelin-dependent inhibition of neurite outgrowth via Lingo-1 repression. J Cell Biol (2011) 0.81
Expression profile and role of EphrinA1 ligand after spinal cord injury. Cell Mol Neurobiol (2011) 0.81
Glial and axonal regeneration following spinal cord injury. Cell Adh Migr (2009) 0.80
Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats. J Neurotrauma (2016) 0.80
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury. Sci Rep (2013) 0.78
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury. Neural Regen Res (2015) 0.78
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Insights into the physiological role of CNS regeneration inhibitors. Front Mol Neurosci (2015) 0.78
Blockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissue. J Mol Neurosci (2011) 0.77
Expression profile of flotillin-2 and its pathophysiological role after spinal cord injury. J Mol Neurosci (2012) 0.77
Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue. Neural Regen Res (2014) 0.76
Rewiring the spinal cord: Direct and indirect strategies. Neurosci Lett (2016) 0.75
Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats. J Spinal Cord Med (2015) 0.75
A Mathematical Model of Regenerative Axon Growing along Glial Scar after Spinal Cord Injury. Comput Math Methods Med (2016) 0.75
Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson's Disease. Front Cell Neurosci (2016) 0.75
Retracted Therapeutic DNA vaccination as a repair strategy following spinal cord injury. Cell Mol Neurobiol (2009) 0.75
Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats. Exp Neurol (2017) 0.75
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature (2000) 5.22
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature (1990) 3.22
Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat Neurosci (1998) 3.15
Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci (2001) 3.11
Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn (2012) 2.98
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature (1995) 2.93
Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA (1997) 2.74
Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron (1988) 2.69
Electrosurgical bipolar vessel sealing versus conventional clamping and suturing for vaginal hysterectomy: a randomised controlled trial. BJOG (2012) 2.66
International standards to document remaining autonomic function after spinal cord injury. Spinal Cord (2008) 2.65
Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature (1994) 2.57
Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain (1981) 2.40
Treadmill training of paraplegic patients using a robotic orthosis. J Rehabil Res Dev (2001) 2.37
Activity of single motor units from human forearm muscles during voluntary isometric contractions. J Neurophysiol (1975) 2.29
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol (1989) 2.20
Long term effects of locomotor training in spinal humans. J Neurol Neurosurg Psychiatry (2001) 2.09
Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol (1988) 1.89
Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J Neurosci (1985) 1.82
Providing the clinical basis for new interventional therapies: refined diagnosis and assessment of recovery after spinal cord injury. Spinal Cord (2004) 1.82
Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry (1999) 1.78
Reaching training in rats with spinal cord injury promotes plasticity and task specific recovery. Brain (2007) 1.78
Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp Neurol (2002) 1.77
NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res (1983) 1.77
Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci (1999) 1.68
Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci (1994) 1.64
Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health (2008) 1.61
Efficient testing of motor function in spinal cord injured rats. Brain Res (2000) 1.61
Neuronal mechanisms of human locomotion. J Neurophysiol (1979) 1.60
Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography. Spinal Cord (2000) 1.59
Driven gait orthosis for improvement of locomotor training in paraplegic patients. Spinal Cord (2001) 1.55
Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci (1998) 1.53
Modulation of spinal neuronal excitability by spinal direct currents and locomotion after spinal cord injury. Clin Neurophysiol (2013) 1.52
Cells of origin, course, and termination patterns of the ventral, uncrossed component of the mature rat corticospinal tract. J Comp Neurol (1997) 1.51
Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res (1984) 1.51
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord (2006) 1.51
Neuronal mechanisms underlying physiological tremor. J Neurophysiol (1978) 1.50
Corrective reactions to stumbling in man: neuronal co-ordination of bilateral leg muscle activity during gait. J Physiol (1984) 1.48
A reliable gait phase detection system. IEEE Trans Neural Syst Rehabil Eng (2001) 1.48
Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J Neurotrauma (2000) 1.47
Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci (2000) 1.45
Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol (1999) 1.45
From spinal shock to spasticity: neuronal adaptations to a spinal cord injury. Neurology (2000) 1.42
Electrophysiological recordings in patients with spinal cord injury: significance for predicting outcome. Spinal Cord (1999) 1.41
Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell Mol Life Sci (2008) 1.41
Low vaccination levels of US preschool and school-age children. Retrospective assessments of vaccination coverage, 1991-1992. JAMA (1994) 1.41
Qualitative course of embryonic O2 consumption in altricial and precocial birds. Respir Physiol (1995) 1.40
Cervical sprouting of corticospinal fibers after thoracic spinal cord injury accompanies shifts in evoked motor responses. Curr Biol (2001) 1.39
Correlation between the dischanges of two simultaneously recorded motor units and physiological tremor. Electroencephalogr Clin Neurophysiol (1976) 1.36
A new global framework for immunization monitoring and surveillance. Bull World Health Organ (2007) 1.36
Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron (1995) 1.35
BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain (2006) 1.34
Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci (1997) 1.33
Corticospinal input in human gait: modulation of magnetically evoked motor responses. Exp Brain Res (1997) 1.32
Vestibular and somatosensory contributions to responses to head and body displacements in stance. Exp Brain Res (1994) 1.31
Interlimb coordination of posture in patients with spastic paresis. Impaired function of spinal reflexes. Brain (1984) 1.31
Corrective reactions to stumbling in man: functional significance of spinal and transcortical reflexes. Neurosci Lett (1984) 1.30
Normal and impaired regulation of muscle stiffness in gait: a new hypothesis about muscle hypertonia. Exp Neurol (1983) 1.30
Gating and reversal of reflexes in ankle muscles during human walking. Exp Brain Res (1990) 1.29
Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J (1987) 1.28
Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra. Brain Res (1979) 1.28
Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J Cell Biol (1979) 1.28
Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc Natl Acad Sci U S A (2001) 1.27
How does the human brain deal with a spinal cord injury? Eur J Neurosci (1998) 1.27
Modulation, probably presynaptic in origin, of monosynaptic Ia excitation during human gait. Exp Brain Res (1996) 1.26
Assessment of autonomic dysreflexia in patients with spinal cord injury. J Neurol Neurosurg Psychiatry (1997) 1.26
Interaction between pre-activity and stretch reflex in human triceps brachii during landing from forward falls. J Physiol (1981) 1.26
Characteristics of postural instability induced by ischemic blocking of leg afferents. Exp Brain Res (1980) 1.25
Compensatory sprouting and impulse rerouting after unilateral pyramidal tract lesion in neonatal rats. J Neurosci (2000) 1.24
Misguidance and modulation of axonal regeneration by Stat3 and Rho/ROCK signaling in the transparent optic nerve. Cell Death Dis (2013) 1.23
Cytokine-induced acute inflammation in the brain and spinal cord. J Neuropathol Exp Neurol (1999) 1.23
Tension development and muscle activation in the leg during gait in spastic hemiparesis: independence of muscle hypertonia and exaggerated stretch reflexes. J Neurol Neurosurg Psychiatry (1984) 1.22
Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci (1999) 1.22
A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics. Brain (1994) 1.20
Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J Neurosci (2000) 1.20
Treadmill training in incomplete spinal cord injured rats. Behav Brain Res (2000) 1.19
Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur J Neurosci (2004) 1.19
Enhancement and resetting of locomotor activity by muscle afferents. Ann N Y Acad Sci (1998) 1.18
Selective binding, uptake, and retrograde transport of tetanus toxin by nerve terminals in the rat iris. An electron microscope study using colloidal gold as a tracer. J Cell Biol (1978) 1.18
Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones. Science (1993) 1.18
Afferent control of human stance and gait: evidence for blocking of group I afferents during gait. Exp Brain Res (1985) 1.17
Adaptational and learning processes during human split-belt locomotion: interaction between central mechanisms and afferent input. Exp Brain Res (1995) 1.17
Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc Natl Acad Sci U S A (1985) 1.16